Harvard Bioscience (HBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,108 | 4,283 | 4,508 | 7,821 | 8,317 |
| Receivables | 14,866 | 16,099 | 16,705 | 21,834 | 17,766 |
| Inventories | 23,245 | 24,716 | 26,439 | 27,587 | 22,262 |
| Other current assets | 2,898 | 3,940 | 3,472 | 4,341 | 3,355 |
| TOTAL | $45,117 | $49,038 | $51,124 | $61,583 | $51,700 |
| Non-Current Assets | |||||
| PPE Net | 5,106 | 3,981 | 3,366 | 3,415 | 3,960 |
| Intangibles | 67,456 | 73,101 | 77,274 | 85,074 | 91,741 |
| Other Non-Current Assets | 8,965 | 11,246 | 13,596 | 12,272 | 8,853 |
| TOTAL | $81,527 | $88,328 | $94,236 | $100,761 | $104,554 |
| Total Assets | $126,644 | $137,366 | $145,360 | $162,344 | $156,254 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 36,956 | 5,859 | 3,811 | 3,235 | 1,721 |
| Accounts payable and accrued liabilities | 4,787 | 5,554 | 6,447 | 4,911 | 5,972 |
| Other current liabilities | 13,215 | 15,129 | 10,856 | 10,762 | 7,478 |
| TOTAL | $54,958 | $26,542 | $23,249 | $25,316 | $21,053 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 30,704 | 43,013 | 45,095 | 46,286 |
| Deferred Revenues | N/A | N/A | N/A | 4,266 | 3,771 |
| Other Non-Current Liabilities | 7,636 | 6,270 | 6,288 | 6,974 | 10,335 |
| TOTAL | $8,346 | $37,750 | $49,891 | $53,627 | $58,520 |
| Total Liabilities | $63,304 | $64,292 | $73,140 | $78,943 | $79,573 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 44,074 | 43,399 | 42,190 | 41,230 | 39,826 |
| Common Shares | 441 | 434 | 454 | 452 | 444 |
| Retained earnings | -158,010 | -145,605 | -142,190 | -132,674 | -132,386 |
| Other shareholders' equity | -15,670 | -14,190 | -15,052 | -10,027 | -12,734 |
| TOTAL | $63,340 | $73,074 | $72,220 | $83,401 | $76,681 |
| Total Liabilities And Equity | $126,644 | $137,366 | $145,360 | $162,344 | $156,254 |